DLA Piper has advised Lightspeed Venture Partners and O.G. Venture Partners on USD 700 million Series C investment in Neko Health

DLA Piper has advised Lightspeed Venture Partners and O.G. Venture Partners in connection with Neko Health's USD 700 million Series C financing round, which is subject to regulatory approval. The round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with participation from existing investors Atomico, General Catalyst and Lakestar, as well as new investors including Liberty City Ventures, Positive Sum, Jimmy Iovine, Maria Sharapova, Mark Zuckerberg and will.i.am.

Lightspeed Venture Partners is a global multi-stage venture capital backing innovative companies across the enterprise, consumer, fintech and healthcare sectors. O.G. Venture Partners is an international multi-stage venture capital firm partnering with exceptional entrepreneurs to build market-leading technology companies.

Founded by Daniel Ek and Hjalmar Nilsonne, Neko Health is a health technology company focused on preventive healthcare. Through its proprietary technology platform and comprehensive health scans, Neko Health aims to transform how people understand and manage their health through early detection and prevention. 

Read more about the Series C financing here.